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ExpressCARE Offers Patients Added
Access to Treatment for Minor Illnesses and
Injuries
By Anthony Friendy, PA-C, with ExpressCARE at LVPG Family Medicine–Whitehall
When you have a full schedule, it can be challenging to fit in patients with acute illnesses and injuries who need
same-day appointments. To offer these patients greater access to acute care, including treatment after hours and
on holidays and weekends, Lehigh Valley Health Network (LVHN) offers ExpressCARE without an appointment
365 days a year.
ExpressCARE offices – there are 12 locations throughout LVHN – are staffed by advanced practice clinicians,
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We also can give flu vaccinations and perform initial workers’ compensation evaluations, STD screenings and low-
complexity physicals. In addition, many ExpressCARE facilities can provide X-ray services.
Although we’re not a substitute for the emergency department (ED), patients sometimes confuse us with one.
Patients who come to ExpressCARE but need emergent care are sent to the ED. We also don’t treat patients with
chronic diseases or prescribe pain or anxiety medication. In addition, we’re not a substitute for a primary care
provider.
Because ExpressCARE is part of LVHN, your patients have access to the full continuum of LVHN services for any
follow-up care they may need. When your patient’s visit with us is complete, we send a copy of the visit to you,
the patient’s primary care provider, through the EMR so that you can stay up-to-date on your patient’s condition
and the treatment he or she has received.
ExpressCARE is open 365 days a year, including weekends and holidays. Patients don’t need an appointment or
a referral, and ExpressCARE is first come, first served. Visit LVHN.org/expresscare for details about hours at each
location.
To learn more about ExpressCARE, call 610-402-CARE.
— Summer 2015
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Assessments Seek to Reduce Risk for
Sudden Cardiac Death
Cardiomyopathy Hypertrophic cardiomyopathy (HCM) affects an estimated one in 500 people, and the genetic
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mutation is the most common cause of sudden cardiac death in young athletes and young adults in general.
Many patients with HCM can live a normal life, which is why specialists in Lehigh Valley Health Network’s (LVHN)
Sports Cardiology and Hypertrophic Cardiomyopathy Program promote education and screening to detect HCM
and stratify risks.
Seeking to raise awareness
“HCM may be misdiagnosed as a condition such as asthma or anxiety, particularly in young people and young
athletes, because it’s difficult to think there is anything wrong with their health,” says LVHN cardiologist Matthew
Martinez, MD, the program’s medical director. “That’s why we work with physicians to evaluate athletes who have
symptoms or a family history of cardiac conditions, or who have undergone imaging that suggests they might be at
risk for sudden cardiac arrest.”
LVHN’s 29 certified athletic trainers (ATCs) provide HCM education and serve as emergency responders for
athletes at area middle schools, high schools and colleges. “All our ATCs are prepared to act immediately to save
a life,” says LVHN’s Robbin Shomper, ATC, MEd, LAT.
HCM treatment
More than 130 patients were referred to LVHN for HCM assessment last year, and cardiology and cardiothoracic
specialists in LVHN’s Heart and Vascular Center currently treat a total of approximately 300 HCM patients. About
two-thirds receive medical therapy to treat or improve symptoms. Other treatments include an implantable
cardioverter defibrillator or myectomy.
“Surgery is generally reserved for adult patients who are either maxed out on medications or experiencing
significant side effects from medications while still having symptoms,” says James Wu, MD, LVHN’s chief of
cardiac surgery.
Wu performs approximately 12 to 15 myectomies annually, and 58 LVHN patients have undergone myectomy.
“We’ve had one of the highest volumes of surgical cases in Pennsylvania in the last four to five years,” Wu says,
“and experience is needed to achieve the best results.”
Symptoms of HCM
Despite its prevalence, HCM is difficult to recognize. Patients of all ages may be asymptomatic or may experience
varied symptoms – such as pounding heart or fatigue – that are attributed erroneously to other disorders.
Providers should watch for athletes who have:
Syncope
Chest pain or pressure
Dyspnea during or after activity
Patients with a family history of HCM also should be screened via echocardiogram or other imaging tests.
1. “Hypertrophic cardiomyopathy: A patient perspective.” R. Nishamura et al. Circ. 2003; 108: e133-e135. 2.
“Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.” M. Frenneaux.
Heart. 2004; 90(5): 570-75.
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To refer a patient to the Heart and Vascular Center, call 610-402-CARE.
— Summer 2015
New Services, Facilities Will Expand Care - Lehigh Valley Health Network - A Passion For Better Medicine
https://www.lvhn.org/for_referring_physicians/better_medicine/inpatient/new_services_facilities_will_expand_care[6/6/2018 10:51:54 AM]
New Services, Facilities Will Expand Care
To further its mission–to heal, comfort and care for
the people of our community–Lehigh Valley Health
Network (LVHN) is constructing new facilities and
expanding services at some of its current locations
in the near future.
Among the projects:
Birthing services at LVH–Muhlenberg
Next month groundbreaking will take place on a new
four-story pavilion on the campus of Lehigh Valley
Hospital (LVH )–Muhlenberg in Bethlehem. The 161,000-square-foot addition will bring births to LVH–Muhlenberg
for the first time in the hospital’s 54-year history. The obstetrics and newborn services will be housed on floors 2
and 3 of the new pavilion and will include:
A mother-baby unit with 20 private rooms
A nursery with 16 bassinets
A Level II NICU with 10 private rooms
Eight state-of-the-art labor, delivery and recovery rooms
Two operating rooms
Five obstetrics triage beds
A three-bay postanesthesia care unit area
A four-bed antepartum unit
When complete, the pavilion will accommodate approximately 2,000 deliveries annually.
The first floor will feature a Center for Inpatient Rehabilitation– Muhlenberg, similar to the Center for Inpatient
Rehabilitation–Cedar Crest that opened earlier this summer at LVH–Cedar Crest in Salisbury Township. The
center will include 28 beds, one ADL (activities of daily living) bed, a gym and an ADL dining/living area.
The fourth floor will be shell space designed to accommodate future growth. The new pavilion is slated to open in
June 2017.
LVHN Cancer Center–Hazleton
Scheduled to open soon, the LVHN Cancer Center–Hazleton will feature three Lehigh Valley Physician Group–
Hazleton hematology oncology providers: Michael Evans, MD; Harvey Hotchner, MD; and Tom Lyons, PA-C. The
Rendering of the Children's Surgery Center.
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LVHN Cancer Center–Hazleton will be located at 388 Airport Road, Hazle Township. It will have seven exam
rooms and eight infusion rooms. Infusion services will include:
Chemotherapy and therapeutic infusions
Transfusion services
Therapeutic phlebotomies and injections
On-site draw station
CLIA-approved tests
Support services will include social workers, dietitians and financial coordinators.
Children’s Surgery Center
To be housed at the 1210 building on the campus of LVH–Cedar Crest, the new Children’s Surgery Center will
provide dedicated space for outpatient pediatric surgeries and will broaden the services available through
Children’s Hospital at LVH, the only children’s hospital in the Lehigh Valley.
Because the center will be located in proximity to other Children’s Hospital features such as the Children’s ER,
pediatrics unit and pediatric intensive care unit (PICU), the Children’s Surgery Center will:
Enhance the patient experience and access to care
Expand and improve existing services and provider/staff satisfaction
Increase the quality, safety and access of our pediatric surgical services, both inpatient and outpatient
Create efficiency while maintaining control of health care costs
Support the Level IV NICU, the PICU, the Level II pediatric trauma center and the pediatric cancer program
The center is scheduled to open in February 2016.
To learn more about any of these locations, call 888-402-LVHN.
— Summer 2015




New trials provide conclusive evidence that acute ischemic stroke patients benefit from mechanical
thrombectomy.  Lehigh Valley Hospital’s (LVH) high-volume Comprehensive Stroke Center shows similar results
Neil Patel, MD
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to those research trials. The center performs 70 thrombectomies annually – the second highest in the mid-Atlantic
region  – and cares for 2,293 total stroke patients each year.
Devices improve outcomes
The four randomized trials show that rapid thrombectomy plus intravenous (IV) thrombolysis improves patient
function more than thrombolysis alone.  This evidence is expected to make thrombectomy the new standard of
care for ischemic stroke over the prior standard, IV tissue plasminogen activator (tPA).
Patients in the trials were treated by neurointerventionalists in stroke centers with organized multidisciplinary
stroke teams. This is the same approach LVH employs. “Comprehensive Stroke Centers like ours provide the
same structural efficiency and algorithmic care that patients benefited from in the recent trials,” says Darryn Shaff,
MD, Lehigh Valley Health Network’s (LVHN) chief of neurointerventional radiology.
Specifically, the LVH stroke team relies on a parallel clinical assessment and decision-making strategy,
administering tPA and preparing an operative suite for thrombectomy while the neurologist and
neurointerventionalist study imaging to determine if large occlusions and sufficient salvageable brain tissue are
present.
“We are very cognizant of the speed of care delivery,” says LVHN neurointerventional radiologist Neil Patel, MD.
“Our approach results in a 40-minute median time from initial imaging to groin puncture for large vessel occlusion.”
Median time in the trails was 51-93 minutes.
LVH also achieved successful reperfusion in 94 percent of patients, while rates in the trials ranged from 58.7 to 88
percent.  Neither LVH nor the trials found significant differences in mortality or symptomatic intercerebral
hemorrhage with thrombectomy.
Specialized stroke treatment
LVH was the first in Pennsylvania and one of the first in the region to be designated a Comprehensive Stroke
Center by The Joint Commission and the American Stroke/Heart Association. It’s an important distinction when
referring or transferring emergency stroke cases that require the highest level of care.
EMS providers and LVH communicate about patients exhibiting signs of stroke, but a more sophisticated
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evidence about the clinical efficacy of an intervention (thrombectomy) is so high, there is an obligation to triage
appropriately and take patients to the center best able to provide treatment,” Shaff says.
Rapid triage of eligible patients to a center skilled at endovascular treatment is now a cornerstone of effective
stroke care. The major trial results indicate that eligible patients who undergo prompt, rapid mechanical
intervention have a 50 percent better chance at returning to independent living after stroke: 50-70 percent of
patients recovered to a modified Rankin Scale of 0-2, versus 29-40 percent of patients who did not receive
endovascular therapy. By working together with EMS providers, the LVH Comprehensive Stroke Center is helping
to bring these benefits to the patients we serve.
1. “A randomized trial of intra-arterial treatment for acute ischemic stroke.” O. Berkhemer et al. N Engl J Med.
2015; 372 (1):11-20.
2. “Endovascular therapy for ischemic stroke with perfusion-imaging selection.” B. Campbell et al. N Engl J
Med. 2015 Feb. Epub before print. 
3. “Randomized assessment of rapid endovascular treatment of ischemic stroke.” M. Goyal et al. N Engl J
Med. 2015 Feb. Epub before print.
4. “SOLITAIRE  FR with the intention for thrombectomy as primary endovascular treatment for acute
ischemic stroke.” J. Saver et al. Presented at the International Stroke Conference, Nashville, TN. February
11, 2015.
5. Medicare Provider Analysis and Review (MedPAR) database.
 
To refer a patient to neurology, call 610-402-CARE.
— Summer 2015
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Expanding Emergency Coverage for
Orthopedic Trauma
VSAS Orthopaedics has long provided on-site emergency department (ED) coverage at Lehigh Valley Hospital
(LVH)–Cedar Crest. Now the practice also has assumed the entire on-call schedule at LVH-Muhlenberg’s ED.
This means patients with acute orthopedic injuries in Lehigh and Northampton counties can see VSAS
Orthopaedics specialists in their local ED and have a fast follow-up visit with subspecialists from the same
practice. Patients can access the same end-to-end orthopedic expertise and coordination across the care
continuum.
“Patients who present to the ED typically have to put in significant work on their own to receive follow-up care,”
says orthopedic surgeon Scott Sexton, MD, chief, section of orthopedic trauma for Lehigh Valley Health Network
(LVHN). “Once they return home, they have to find an orthopedic physician in the area, call their insurance and
call their primary care physician. Now, when patients are evaluated at either LVH emergency facility, they can
transition to an office visit with an orthopedic specialist immediately, without that hassle.”
Same-day follow-up care
When patients are evaluated in either ED facility, VSAS Orthopaedics has committed to providing a timely follow-
up office visit with an orthopedic subspecialist who has expertise in their injury. In addition to providing care for
injured adults, the VSAS team includes a pediatric orthopedic trauma specialist, Berry Berger, MD, available for
children’s very special needs.
Scott Sexton, MD
Orthopedic surgery
Watch a video to learn more about him.
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VSAS has offices adjoining both hospitals and offers early evening hours on most days. If an injury occurs at
night, patients can call the office the following morning and in many cases be seen the same day.
“We have a large group of orthopedic surgeons who can deal with anything from simple sprains to the most
complex musculoskeletal injuries,” Sexton says. “We maintain close communication with ED staff and can access
imaging studies from our offices over our hospital-integrated system. We can direct the patient to the most
appropriate next step and get him or her headed on the road to recovery immediately.”
A unique combination
The expanded orthopedic coverage builds on LVHN’s track record of leadership in emergency care. LVH was
Pennsylvania’s first Level I Trauma Center. With VSAS Orthopaedics joining Lehigh Valley Physician Group,
LVHN can go even further to make end-to-end orthopedic trauma care faster and easier for patients regionwide.
“It’s rare to have this degree of seamless transition, from the ED evaluation to the implementation of orthopedic
care and follow-up,” Sexton says. “We understand that these patients are in pain and have limited mobility, and
we make getting care as easy for them as possible.”
To refer a patient to the orthopedic trauma program, call 610-402-CARE.
— Summer 2015
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Pilot Program Targets CHF Patients
Chronic heart failure (CHF) causes more U.S. hospitalizations than all forms of cancer combined.  Moreover, the
national hospital readmission rate within the first 30 days of discharge is approximately 24 percent.
To help CHF patients thrive and avoid preventable readmissions, Lehigh Valley Health Network (LVHN) is piloting
a Community Care Team program at two practices, LVPG Internal Medicine−Muhlenberg  and LVPG Family
Medicine−Trexlertown. CHF patients are enrolled in the program upon hospital discharge; providers also can refer
CHF patients who would benefit from close follow-up.
The goal is to educate patients about the importance of disease self-management via consistent and repetitive
messaging throughout the care continuum.
“CHF patients must adhere to strict dietary, fluid and medication restrictions, so they need to understand their role
in managing the disease,” says Kay Rauchfuss, MSN, CCRN, LVHN patient care services administrator for the
cardiac service line. “We’re focused on helping them learn what they need to do to stay well.”
Consistent messages
Throughout the service line, patients are consistently told the same information –for example, “Call your doctor if
you gain two pounds overnight” – before hospital discharge, on discharge phone calls, in take-home patient
education materials and during follow-up visits. “Repetitive messages that focus on the same statement are less
confusing and improve retention,” Rauchfuss says.
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postdischarge, we re-evaluate medications and reteach, ensuring patients have a full understanding of their
medications and their disease process,” says LVHN outpatient nurse practitioner Alma Ohl, CRNP. “Patients are
taught to recognize when they’re getting into trouble and when to call if they have symptoms.” If a patient has an
acute problem, such as feeling short of breath, he or she often is seen as an outpatient the same day.
Medication management
The pilot program also includes pharmacist follow-up calls at seven, 14, 21 and 28 days after hospitalization. “We
review signs and symptoms of heart failure, how to use medications and the consequences of missing doses or
not sticking to their diet,” says LVHN Community Care Team pharmacist Meredith Dempsey, PharmD.
Of the 13 patients who have participated in the pilot program to date, preliminary data indicates that hospital
utilization decreased 63 percent.
“From a population health perspective, our long-term goal is to keep patients healthier longer,” Dempsey says.
“Overall, patients are happy with the program because they get a lot of information and support.”
1. The Heart Failure Society of America. hfsa.org/hfsa-wp/wp/patient/questions-about-heart-failure/.
2. “Rehospitalization for heart failure: Predict or prevent?” A. Desai et al. Circ. 2012; 126: 501-06.
To refer a patient to the CHF pilot program, call 610-402-CARE.
— Summer 2015
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Revised Allocation System Increases
Chance for Receiving Donor Kidney
The average wait time for a kidney transplant is five years.  The day often never comes, however, for highly
sensitized patients – those with antibodies against 97 to 100 percent of the population.
Such patients have the highest risk for kidney rejection. Over a 10-year period, only one Lehigh Valley Health
Network (LVHN) patient with 100 percent antibody noncompatibility received a donated kidney.
That’s why, last December, LVHN joined a new national kidney allocation system that uniformly increases highly
sensitized patients’ odds of receiving an organ.
The new system already has led to more frequent transplants. “In the six months since it began, we’ve
transplanted 10 patients who were either 99 or 100 percent noncompatible,” says LVHN transplant surgeon
Michael Moritz, MD, with LVPG Transplant Surgery–1250 Cedar Crest. “All patients are off dialysis and doing
fine.”
Casting a wider net
The new system brings many changes to the transplant allocation process. They include making donor kidneys
available over a broader geography to better serve highly sensitized patients.
Previously, the system limited such patients to local donors. Now, patients with 99 percent noncompatibility –
Michael Moritz, MD
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Watch a video to learn more about him.
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those who produce antibodies against 99 percent of other humans – receive regional priority for donor kidneys that
become available. Patients with 100 percent noncompatibility receive national priority.
Moreover, the new system for the highly sensitized isn’t focused on the length of time patients are on the kidney
transplant waiting list. “Highly sensitized patients get a donor kidney when the perfect one comes along,” Moritz
says. If there’s a donor kidney available in Kansas, for example, the new system checks all the 100-percent
patients nationwide for compatibility.
Quieting the immune response
Patients can acquire antibodies against other people from blood transfusions, previous transplants or pregnancies.
Their immune systems are more reactive than usual. To help highly sensitized patients accept their donor kidney,
Moritz and his team do everything possible to help the organ function – and continue to function.
Patients undergo pretransplant plasmapheresis, which replaces plasma with antibody-free protein to deplete
the antibody load in the bloodstream.
Recipients receive a B cell−depleting agent post-transplant.
Sensitized patients follow a protocol in which they receive intravenous immunoglobulin (IVIG) infusions once a
month for four months. “We’ve shown that IVIG can decrease the risk for antibody-mediated rejection by two-
thirds,” Moritz says.
Patients take three immunosuppressant drugs chronically rather than the usual two, increasing their overall
immunosuppression.
1. Gift of Life Donor Program.
To refer a patient for the kidney transplant program, call 610-402-CARE.
— Summer 2015
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Better Tools More Accurately Assess
Prostate Cancer Risk
Determining the appropriate course of treatment for prostate cancer has been an enduring challenge for providers.
Given the slow growth of the cancer and the side effects of treatment, active surveillance often is best. Yet
sometimes providers and patients have anxiety about forgoing treatment. The biggest barrier: The traditional
clinical tools available to make this determination have not been as accurate as providers would like.
“Prostate cancer survival rates are typically very good overall, but we wondered how we can determine the true
biologic potential of the cancer when a patient is initially diagnosed,” says Angelo Baccala Jr., MD, chief of urology
at Lehigh Valley Health Network (LVHN). “How can we know for certain when we need to treat?”
Now, LVHN physicians are using new genetic testing and biopsy strategies to dramatically improve prostate
cancer risk assessment and diagnosis.
Assessing risk
Conventional risk stratification models combine prostate-specific antigen (PSA) test results, Gleason score, biopsy
results and other pathologic data to assess a patient’s suitability for active surveillance. These parameters can
provide a good indication of population-level risk, but individual risk varies widely. Today, LVHN providers can
provide a much more accurate evaluation.
When patients are diagnosed with prostate cancer, LVHN providers use multiparametric MRI to identify clinically
Angelo A. Baccala Jr., MD
Urology
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significant tumors to target for biopsy. Using new fusion technologies, they can combine that MRI image with
ultrasoundguided biopsy to obtain cells from only suspicious lesions, rather than relying on random sampling.
Next, they employ new oncotyping strategies to analyze tumors’ cells. Using a 17-gene assay, they can obtain the
precise molecular signature of an individual’s prostate cancer. This allows providers to predict the biologic
progression of the cancer more accurately.
“We gain much more confidence that we’re choosing the right patients for active surveillance,” Baccala says. “And
we do a much better job of identifying patients who may appear to be low-risk but have unfavorable biology that
merits treatment.”
Improving diagnosis
New genetic markers, identified in the last year, also improve the accuracy of initial cancer diagnoses with a urine
test. Using nucleic amplification testing, LVHN providers can measure the concentration of prostate cancer gene 3
(PCA3), which is present in 97 percent of cases.
“It’s common for a patient to have a high PSA but a negative biopsy, and the physician may still be suspicious the
patient has cancer,” Baccala says. “We can use the PCA3 test, perform an MRI and then determine next steps.
This is a huge benefit to patients, because historically they may have been subjected to four or five biopsies. Now,
it’s possible none of them are necessary.”
To refer patients to urology, call 610-402-CARE.
— Summer 2015
Multiparametric MRI can identify prostate tumors to target for biopsy.
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Maternal Fetal Medicine, Cardiology
Collaborate on High-Risk Pregnancies
More women with congenital or acquired cardiac
disease are reaching reproductive age and
achieving pregnancy, requiring complex care that
addresses both cardiovascular and maternal fetal
health. Lehigh Valley Health Network (LVHN)
optimizes such care through the region’s first heart
and pregnancy program.
A focused approach
The program, which includes LVHN’s large
contingent of high-risk pregnancy specialists, is one
of the largest in Pennsylvania and the nation. It’s
part of LVHN’s Heart and Vascular Program for
Women, which provides specialized care for and
prevention of heart disease in women at all stages
of life. More than 180 patients with cardiac issues
have been treated through the heart and pregnancy
program since its inception in 2010.
LVHN’s comprehensive, multidisciplinary team
approach includes maternal fetal medicine (MFM)
specialist Joanne Quiñones, MD, and LVHN
cardiologist Amy Ahnert, MD, with LVPG Cardiology.
“Pregnancy has significant impact on the cardiac
system for all patients, and women with pre-existing
conditions, risk factors or cardiac complaints must
be closely monitored and assessed by specialists
who work together as a team,” says Quiñones, an
obstetrician who completed a three-year MFM
fellowship. MFM subspecialists have advanced
knowledge of the medical, surgical, obstetrical, fetal
and genetic complications of pregnancy and their
effects on both the mother and the fetus.
Approximately 1 to 3 percent of all pregnant women
Amy Ahnert, MD
Cardiology
Watch a video to learn more about her.
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will experience cardiac complications, which are
responsible for 10 to 15 percent of maternal
mortality.  Hypertension is the most common
medical problem during pregnancy, complicating
approximately 15 percent of all pregnancies.  Other
disease categories the team treats include:
Congenital structural issues (congenital heart disease, valvular disease, coarctation of the aorta)
Acquired structural disease (rheumatic heart disease, prosthetic valves, electrical disorders, Marfan syndrome,
coronary artery disease)
Functional disorders (hypertension, arrhythmias, cardiomyopathy)
Some women also may present with cardiac complaints (palpitations, near syncope, dizziness or chest
pain/pressure) without a history of cardiac disease.
Pregnancy counseling
Women with known cardiac disease or risk factors ideally should receive evaluation and counseling prior to
conception or early in pregnancy.  Although the risk during pregnancy depends on the patient and her specific
heart disease, the LVHN team identifies and quantifies risks to mother and fetus through personal and family
health history, imaging and other assessments. The program’s clinical team provides preconception counseling for
women with issues such as congenital heart block, prosthetic heart valves, bicuspid aortic valves and inherited
arrhythmias such as catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome,
hypertrophic cardiomyopathy and Marfan syndrome, among others.
Collaborative management of patients
While early diagnosis and counseling are important, the majority of women referred to the program are pregnant
and past the midpoint of their pregnancies. The specialists schedule appointments together so that cardiac and
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“It’s a very dynamic visit, with information gathered and shared among the clinicians and the patient,” Quiñones
says. “Patients benefit from that kind of interaction and appreciate the coordination among specialists.”
Cardiac output increases during labor and delivery, making this period of pregnancy potentially dangerous for
pregnant women with cardiac disease. In particularly complex cases, the team conducts simulations to prepare for
deliveries by women with cardiac disease. These simulations are taught by members of the obstetrics simulation
team (obstetric nurses, MFM specialists and cardiology fellows) and include residents, nursing staff from the labor
and delivery unit and progressive care unit, and other providers.
Sharing results
LVHN’s division of MFM educates obstetric caregivers on complex pregnancy care in a variety of forums. In 2014,
Quiñones and her cardiology and MFM colleagues presented two posters at the third International Congress on
Cardiac Problems in Pregnancy in Venice, Italy. The studies focused on the program’s collaborative cardiology
and MFM practice and the role of cardiac MRI during pregnancy . Ahnert, Quiñones and anesthesiologist Rafael
Martinez, MD, with Allentown Anesthesia Associates, also shared their experiences treating a woman with CPVT,
presenting at the 2014 annual meeting of the International and North American Societies of Obstetric Medicine.
“CPVT is a very rare disease, occurring in only 1 in 10,000 patients, and many cardiologists will never see a case
in their career,” Ahnert says. “Our experience with CPVT was successful in that the patient was able to carry to
term and have a successful delivery. The patient is now contemplating a second pregnancy, and our team will be
there to help her.”
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To refer a patient to the heart and pregnancy program, call 610-402-CARE.
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